The stereochemical requirements of the novel δ-opioid selective dipeptide antagonist TMT-Tic
摘要:
Five conformationally constrained dipeptide TMT-L-Tic analogues have been synthesized and evaluated for their bioactivity using in vitro bioassays. The most potent and selective analogue (2S,SR)-TMT-L-Tic showed 9 nM binding affinity and 4000-fold selectivity for the delta vs mu opioid receptor. The lowest-energy conformation of(2S,3R)-TMT-L-Tic is suggested to be bioactive one in which the chi(1) torsional angle is trans for TMT and gauche (+) for Tic. (C) 1997 Elsevier Science Ltd.
The stereochemical requirements of the novel δ-opioid selective dipeptide antagonist TMT-Tic
摘要:
Five conformationally constrained dipeptide TMT-L-Tic analogues have been synthesized and evaluated for their bioactivity using in vitro bioassays. The most potent and selective analogue (2S,SR)-TMT-L-Tic showed 9 nM binding affinity and 4000-fold selectivity for the delta vs mu opioid receptor. The lowest-energy conformation of(2S,3R)-TMT-L-Tic is suggested to be bioactive one in which the chi(1) torsional angle is trans for TMT and gauche (+) for Tic. (C) 1997 Elsevier Science Ltd.
[EN] PROCESS FOR THE PREPARATION OF AMIDES OF N-[1-(S)-(ETHOXYCARBONYL)-3-PHENYLPROPYL]-L-ALANINE<br/>[FR] PROCÉDÉ DE PRÉPARATION D'AMIDES DE N-[1-(S)-(ÉTHOXYCARBONYL)-3-PHÉNYLPROPYL]-L-ALANINE
申请人:SANOFI AVENTIS DEUTSCHLAND
公开号:WO2014202659A1
公开(公告)日:2014-12-24
A process for the production of amides of N-[1-(S)-(ethoxycarbonyl)-3-phenylpropyl]-L-alanine is described. The process can be used for the production of key intermediates and finally the ACE inhibitors such as Ramipril, Enalapril, Quinapril, Trandolapril, Delapril and Moexipril starting from N-[1-(S)-(ethoxycarbonyl)-3-phenylpropyl]-L-alanine by the reaction with the appropriate amines.
Studies on neurokinin antagonists. 1. The design of novel tripeptides possessing glutaminyl-D-tryptophylphenylalanine sequence as substance P antagonists
To discover a novel and low molecular weight substance P (SP) antagonist we postulated that the essential binding domain of peptide ligands was only a small portion in the whole structure. On the basis of this assumption, we selected the known octapeptide SP antagonist D-Pro-Gln-Gln-D-Trp-Phe-D-Trp-D-Trp-Phe-NH2 (1) as a lead and synthesized its fragment tripeptides which were evaluated for their activity to block H-3-SP binding on guinea pig lung membranes. The protected tripeptide N(alpha)-[N(alpha)-[N(alpha)-(tert-butyloxycarbonyl)-L-glutaminyl]-N1-formyl-D-tryptophyl]-L-phenylalanine benzyl ester [Boc-Gln-D-Trp(CHO)-Phe-OBzl (4a)], corresponding to the Gln-D-Trp-Phe part of 1, exhibited 7-fold potent inhibitory activity in comparison with 1. Studies on structure-activity relationships revealed that the D-tryptophan, L-phenylalanine, and benzyl ester were quite important to maintain the high binding affinity. It was also indicated that 4a antagonized the SP-induced contraction of isolated guinea pig trachea strips (IC50 = 4.7 x 10(-6) M).